VivoSim Labs, Inc. Market Cap ($1.92 Million)
Market Cap & Net Worth: VivoSim Labs, Inc. (VIVS)
VivoSim Labs, Inc. market cap. VivoSim Labs, Inc. (NASDAQ:VIVS) has a market capitalization of $1.92 Million ($1.92 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30072 globally and #6136 in its home market, demonstrating a -5.53% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying VivoSim Labs, Inc.'s stock price $0.14 by its total outstanding shares 13390789 (13.39 Million). Also see how efficiently does VivoSim Labs, Inc. generate cash for how efficiently the company converts equity into cash flow.
VivoSim Labs, Inc. Market Cap History (2025–2026)
VivoSim Labs, Inc. market cap history from 2025 to 2026. Data shows change from $24.24 Million to $1.92 Million (-81.33% CAGR). Check current stock price of VivoSim Labs, Inc. for real-time trading data and today's change.
VivoSim Labs, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how VivoSim Labs, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore VivoSim Labs, Inc. net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
14.68x
VivoSim Labs, Inc.'s market cap is 14.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $24.24 Million | $144.00K | -$2.49 Million | 168.31x | N/A |
| 2026 | $1.92 Million | $131.00K | -$13.84 Million | 14.68x | N/A |
Competitor Companies of VIVS by Market Capitalization
Companies near VivoSim Labs, Inc. in the global market cap rankings as of November 4, 2026. Also see VIVS total asset value for a full breakdown of the balance sheet.
Key companies related to VivoSim Labs, Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of VivoSim Labs, Inc. (2025–2026)
Market capitalization of VivoSim Labs, Inc. from 2025 to today. Between 2025 and today, VivoSim Labs, Inc.'s market cap moved from $24.24 Million to $ 1.92 Million, with a yearly change of -81.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.92 Million | -92.07% |
| 2025 | $24.24 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of VivoSim Labs, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.92 Million USD |
| MoneyControl | $1.92 Million USD |
| MarketWatch | $1.92 Million USD |
| marketcap.company | $1.92 Million USD |
| Reuters | $1.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About VivoSim Labs, Inc.
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models. The company also provides liver toxicology predictive screening and research services, as well as… Read more